JRSBRT HomeIssue Contents

ISRS Society News

ISRS 2013

The 11th congress will take place in Toronto, Ontario, Canada, 16-20 in June 2013.

ISRS 2013 meeting will be held in Toronto, Ontario, Canada during June 16-20, 2013. Toronto is easily accessible from all major cities around the world and the official hotel, The Sheraton, is located in the heart of downtown Toronto. It is one of the most culturally diverse cities in the world with lots to offer, with world class theater, opera, fine dining, and museums to enjoy. Niagara Falls and Niagara wine regions are in a close distance. Toronto has also been a leader in radiosurgery with its program starting right at the beginning of brain radiosurgery in North America. The University of Toronto is one of the largest programs in the world, both in neurosurgery and in radiation oncology. We can all make the ISRS 2013 a major success.

Call for abstract has been announced. Abstracts can only be submitted online until November 4, 2012. Abstracts and documents must be submitted in English. Everyone is encouraged to report the results of original research in stereotactic radiosurgery and SBRT, and any related fields that have not been published whole or in part elsewhere. Information of ISRS 2013 registration and abstract submission information can be found http://www.isrscongress.org.

VUmc International Symposium on SBRT in Amsterdam, December 6-8, 2012

On December 6-8 2012, the 2nd international VUmc symposium on Stereotactic Ablative Radiotherapy (SABR) will be organized in Amsterdam, The Netherlands. SABR has rapidly become an essential component of modern radiation oncology. Knowledge and/or availability of SABR will be essential for all multidisciplinary teams.

The symposium will emphasize a structured approach for assessing and treating suitable patients. In keeping with the practice-oriented nature of the course, a series of cases will be presented during interactive practical sessions illustrating low and high-risk scenarios and giving examples of where SABR was not performed. For each SABR case, choice of pre-treatment imaging, treatment planning constraints, delivery techniques, and in-room imaging will be highlighted.

This symposium is designed for clinicians, physicists and radiotherapy technologists who are either setting up a SABR program, or those who wish to implement SABR for more complex and challenging cases or new indications. The practical nature of the course will also benefit residents, physicists-in-training and employees of health-care firms. For more information and registration: contact Prof. Dr. Ben Slotman, Chair of organizing committee, or visit www.sbrt.eu.
Full Text (IP)